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Abstract: In this study, a zinc(II) phthalocyanine compound (PcZn) substituted with octakis phenoxyacetamide was
synthesized and characterized. Calf thymus DNA (CT-DNA) was used to determine the DNA binding properties of the
zinc(II) phthalocyanine compound. This interaction of CT-DNA with PcZn was investigated using electronic absorption
spectra, emission spectroscopy, a thermal melting temperature study, cyclic voltammetry, and viscosity measurements
in a Tris-HCl buffer solution at a pH of 7.2. The findings showed that zinc(II) phthalocyanine interacts with calf thymus
DNA via partial intercalative binding mechanisms. In addition to the techniques above, a gel electrophoresis study was
also carried out to verify the interaction of CT-DNA with the PcZn complex. The results demonstrated that the octakis
phenoxyacetamide-substituted zinc(II) phthalocyanine complex binds to CT-DNA via a partial intercalative binding
mode.
Key words: DNA binding, absorption spectroscopy, gel electrophoresis, thermal melting, phthalocyanine compound

1. Introduction
Many people suffer from deadly forms of cancer, and many patients worldwide die each day because of this
disease. 1 It is known that cancer is one of the most serious health issues across the world and it is anticipated
that the disease will continue to kill many people in the coming years. 2 Because of this, cancer therapy and
studies on inhibiting cancers have acquired major significance. Therefore, the design of therapeutic cancer
medicine is very important to combat this deadly disease.
Metallophthalocyanine compounds have many significant chemical features because of their structures.
These compounds are highly useful in different types of medical applications. 2,3 Recently, in the published literature, many scientists have paid particular attention to the cell cycle and the DNA molecule. 3 The interaction
of drugs with DNA molecules is a very important approach in the design of cancer medicines. 4 Therapeutic
chemical compounds have very significant properties that let them bind to DNA or hinder the resting of DNA
molecules. 4 The binding of drugs to DNA molecules can alter the structure of DNA and the duplication or
transcription of DNA. 5 The binding of drug agents to DNA can end variations in DNA replication. 6 This
interaction is thought to be where the major binding modes of tiny drug molecules to DNA occur through
intercalative and nonintercalative binding mechanisms. 5,6 There are several major DNA binding modes of
metallophthalocyanine compounds to DNA. These binding mechanisms are intercalation or external binding.
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Intercalation binding mode is the mechanism where small molecules penetrate themselves in between DNA base
pairs. External binding, such as electrostatic, dipole-dipole, and hydrogen binding interactions between DNA
and intercalators, is a substantial binding mechanism. Hydrogen binding and electrostatic attraction are the
major binding forces in groove binding. 2,4
In the recent literature many studies have been conducted on the interaction of phthalocyanine compounds
with DNA. The phthalocyanine compounds bearing different groups interact with DNA via intercalation or
nonintercalation binding mechanisms. 7 The chemical reactivities of phthalocyanine compounds can be changed
by altering the peripheral ligands and central metal cations. 8 In addition, phenoxyacetamide-substituted zinc(II)
phthalocyanine compounds are biologically effective molecules. A zinc(II) phthalocyanine compound bearing
octakis phenoxyacetamide ligands can have potential applications, for example in cancer therapy 9 and in
antibacterial 10 treatment.
The interaction of phthalocyanine compounds with DNA molecules to prevent the spread of cancerous
cells has gained great attention. In the published literature, there are many interesting studies carried out in
this area. These kinds of compounds can be very useful for increasing the anticancer therapy research. 2 In the
published literature, the binding properties of tetracationic zinc and metal-free phthalocyanine compounds have
been studied. 11 The findings of these studies demonstrated that water-soluble quaternized zinc and metal-free
phthalocyanine compounds interact with DNA molecules. 11,12 According to another study of a water-soluble
morpholine zinc(II) phthalocyanine complex, it was shown to interact with calf thymus DNA (CT-DNA) through
intercalation binding mechanisms. 13 The results of another study demonstrated that cationic phthalocyanines
can interact with DNA via nonintercalation binding mechanisms. 14 The studies of tetra-substituted zinc(II),
manganese(III), and copper(II) phthalocyanine compounds indicated that the compounds bind to DNA through
intercalative binding modes. 15 A copper hexamethyleneimino-ethoxy-substituted phthalocyanine compound
was studied. The compound showed that it has a strong interaction with DNA. 16 Additionally, the binding
properties of a cationic photobleachable cobalt and of palladium phthalocyanines with CT-DNA were also
reported. The results of this study showed that the phthalocyanine compounds bind to DNA molecules. 16
In this study, the DNA binding activities of the previously synthesized octakis phenoxyacetamidesubstituted zinc(II) phthalocyanine compound (PcZn) 17 with CT-DNA were studied using absorption spectral
titration, emission spectroscopy, a thermal melting temperature study, viscosity measurements, cyclic voltammetry, and gel electrophoresis techniques.
2. Results and discussion
2.1. Synthesis and characterization
As shown in Figure 1, an octaphenoxyacetamidephthalocyaninatozinc(II) compound was synthesized and characterized using NMR, FTIR, UV/Vis, and elemental analysis 17 , and results showed good agreement with earlier
results of studies in the published literature.
2.2. Absorption studies
In general, the interaction of a tiny metal complex with DNA molecules relates to the changes in hyperchromism
or hypochromisms and the blue shift or red shift in the wavelengths of the absorption spectra. 6 The binding
mechanisms, such as intercalation, usually relate to hypochromisms and red shifts. 6 In general, weak binding shows no change in absorbance levels. 6,8 The intercalative binding mode of a tiny compound leads to
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Figure 1. The structure of the zinc(II) phthalocyanine compound (PcZn).

hypochromism with blue shifts or red shifts because of a very powerful arrangement of aromatic parts and DNA
base pairs. 18,19 . Absorption spectral titration is a very important method in the study of the interaction of
metal complexes with DNA molecules.
In the current study, the absorption spectra of the octakis phenoxyacetamide-substituted zinc(II) phthalocyanine compound (PcZn) were studied using a UV/Vis spectroscopy technique. The absorption titration
spectra of PcZn (15 µ M) were conducted between wavelengths of 300 and 800 nm in the absence of CT-DNA.
The electronic spectra of PcZn showed the characteristic absorption spectra in Q bands at 680 nm and 660
nm wavelengths in DMF, as shown in Figure 2. In order to investigate the interaction of PcZn with CT-DNA,
absorption titrations were carried out in the presence of CT-DNA, and they showed changes in absorbance
bands in a Tris-HCl buffer solution at a pH of 7.2. The absorbance bands of PcZn dropped in intensity without
changing the conformation of bands after increasing the amounts of CT-DNA. The changes in the absorbance
bands of PcZn during titration with CT-DNA are indicated in Figure 2. The drop in intensities of absorption spectra of PcZn demonstrates the existence of intercalative binding modes between CT-DNA and the
PcZn compound. When the concentrations of CT-DNA were increased from 0.5 to 5 µ M, a hypochromism
was formed with change in the wavelengths of the absorption spectra. A considerable change in hypochromism
demonstrates that PcZn interacts with CT-DNA. These results showed that PcZn binds to CT-DNA through
a partial intercalation binding mode. The binding constant (Kb) of PcZn with CT-DNA was calculated using
the Wolfe–Shimer equation (Eq. (1)). The Kb constant of PcZn was computed to be 1.43 × 10 6 M −1 . The Kb
constant demonstrates that PcZn interacts with CT-DNA through a partial intercalation binding mechanism. 20
In addition to the absorption titration experiments, related binding studies were carried out to verify the
interaction of PcZn with CT-DNA using an ethidium bromide (EB) compound, which is widely used as an
intercalator to determine DNA binding mechanisms. 20 In this technique, the chemical compounds bind to the
DNA molecule through intercalative binding mechanisms as EB changes sides in the EB and DNA complex,
observed by the intensities of the absorption spectra. 21 As indicated in Figure 3, absorption spectra for the
1312
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Figure 2. Electronic spectra of PcZn in a Tris-HCl buffer at a pH of 7.2 with increasing amounts of CT-DNA. Arrows
indicate the absorption spectra changes with increasing amounts of CT-DNA.

related binding experiments were performed with wavelengths of 510 nm to 400 nm. The intensity of absorption
spectra for EB around 460 nm dropped and changed with increasing concentrations of CT-DNA. When 1 to
5 µ M of PcZn was combined with the CT-DNA and EB complex, the intensities of the absorption spectra
were increased, as shown in Figure 3. The results demonstrated that PcZn changed sides when comparing EB
to CT-DNA and EB. As a result, it is shown that PcZn binds to CT-DNA via partial intercalative binding
mechanisms.
2.3. Emission titration studies
The emission titration technique is widely used in studies of the interaction of DNA molecules with metal
complexes. This technique provides more information on the interaction between metal complexes and the

Figure 3. Absorption titration results for free EB and EB bonded to CT-DNA with increasing amounts of PcZn in
the absence and presence of PcZn.
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DNA molecule. Emission titration experiments are performed to investigate the binding properties between
the DNA molecules and small metal compounds. 22 The emission titration experiments were carried out in
the absence and presence of CT-DNA to determine the interaction of CT-DNA with PcZn. The zinc(II)
phthalocyanine compound produced emission spectra in the absence of CT-DNA in a Tris-HCl buffer at a pH
of 7.2 with a peak appearing at a wavelength of approximately 670 nm (black line), as indicated in Figure 4.
An increase in intensity of the emission spectra of PcZn was monitored in the presence of CT-DNA in Tris-HCl
at a pH of 7.2 with respect to the intensity of emission spectra of the original PcZn, as shown in Figure 4.
For increasing concentrations of CT-DNA (5 µ M (purple line), 10 µ M (red line), and 15 µ M (green line)),
PcZn produced emission bands at wavelengths of approximately 605, 610, and 645 nm. The emission spectra
in the absence and presence of DNA were different. The emission titration spectra experiments were repeated
several times and almost the same results were obtained. We speculate that the difference of emission spectra
of in the absence and presence of DNA may be due to the type of binding mechanism of CT-DNA with PcZn
and the structure of the PcZn compound. The intensities (I ) of fluorescence titration spectra of the PcZn
compound in a Tris-HCl buffer solution (pH 7.2) at room temperature in the absence and the presence of calf
thymus DNA increase, changing upon increasing amounts of CT-DNA. 23 These findings demonstrated that the
phthalocyanine compound binds to the CT-DNA molecule. 23

Figure 4. Fluorescence titration spectra of PcZn compound (10 µ M) (black line) in a Tris-HCl buffer solution (pH
7.2) at room temperature in the absence and the presence of CT-DNA. Arrow indicates the intensity changing upon
increasing amount of CT-DNA, where I shows intensity.

2.4. Thermal melting temperature study
In this study, thermal melting temperature ( Tm ) experiments were conducted on CT-DNA in the absence
and presence of PcZn to investigate the binding activities of the PcZn complex with CT-DNA. The melting
1314
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temperature of the DNA provides significant knowledge regarding the properties of the DNA double-stranded
helix with changes in temperature at a 260 nm wavelength. 21 The intercalative binding mechanisms of metal
complexes with the DNA molecule increase the melting temperatures because of the efficiency of binding,
whereas nonintercalative binding modes for metal complexes with DNA drop or stay the same. 22 In the
absence and presence of PcZn, the thermal melting temperatures of CT-DNA were determined using UV/Vis
spectroscopy. The results of the thermal melting temperature study are shown in the Table. In the absence of
the compound, the thermal melting temperature of CT-DNA was found to be 74.83 ◦ C, as shown in Figure 5.
The melting temperature in the presence of PcZn was found to be 82.76 ◦ C, as in Figure 5. These findings
showed that the PcZn compound interacts with CT-DNA via partial intercalation binding mechanisms because
of an increase in thermal melting temperature values.
Table. The thermal melting temperatures ( Tm ) of CT-DNA in the absence and presence of PcZn complex.

CT-DNA
CT-DNA + PcZn

Thermal melting temperature (Tm )
74.83 ◦ C
82.76 ◦ C

Figure 5. Thermal melting temperature profile of CT-DNA in the absence of PcZn (blue line) and in the presence of
PcZn (orange line).

2.5. Cyclic voltammetry study
Cyclic voltammetry is one of the techniques commonly applied to investigate the interaction of metal complexes
with DNA molecules. The technique provides significant information for the initial assessment of the study of
electronic absorption spectra. 23 When metal compounds interact with the DNA molecule, the peak potential
and peak current of the complexes shift in the presence of the DNA molecule. 24
In this study, a cyclic voltammetry experiment was performed to investigate the interaction of PcZn
with CT-DNA in the absence and presence of CT-DNA in a Tris-HCl buffer at a pH of 7.2. The findings are
shown in Figure 6. In the absence of CT-DNA (blue line), the PcZn compound produced a couple of peaks
related to PcZn that indicated the cathodic (EPc) peak potential and anodic peak potential (EPa). The EPc
and EPa were found to be approximately –0.41 V (EPc) and –0.39 V (EPa) for PcZn, as indicated in Figure 6.
The cyclic voltammetric peak current decreased considerably in the presence of CT-DNA. The reduction
of peak current upon the addition of CT-DNA is attributed to the small diffusion 25,26 of the PcZn compound
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binding to the DNA molecule. The EPc and EPa were observed to be –0.45 V (EPc) and 0.15 V and 0.80 V
(EPa) for PcZn, as indicated in Figure 6 (red line) at a fixed concentration of PcZn. This showed a successive
drop in peak current. The peak potential and the peak current of the compound showed that CT-DNA binds
to the PcZn compound via a partial intercalation binding mode.

Figure 6. Cyclic voltammetry diagram for PcZn in the
absence of CT-DNA (blue line) and the presence of CTDNA (red line). Arrows indicate drop in cathodic peak
potential (EPc) in the presence of CT-DNA.

Figure 7. The gel electrophoresis diagram for CT-DNA
in a Tris-HCl buffer solution at a pH of 7.2 in the absence
and presence of PcZn. Lanes 1 to 3 belong to CT-DNA
(15 µ M) and PcZn (5, 10, 20 µ M), respectively. C is the
control CT-DNA and M is the DNA marker.

2.6. Gel electrophoresis study
In this part of the study a gel electrophoresis technique 27,28 was used to study the interaction of the zinc(II)
phthalocyanine compound with CT-DNA molecules at room temperature in the absence and presence of PcZn.
The binding activities of CT-DNA with PcZn were investigated to confirm the impact of variable amounts
of PcZn on the DNA. It is very clear that the intensities of the DNA bands were considerably decreased
for increasing concentrations of PcZn. The bands of CT-DNA were visualized under UV light, as indicated in
Figure 7. The drop in the intensities of bands of CT-DNA after the binding of PcZn to CT-DNA was due to the
degeneracy of the DNA double-stranded helix. 7,29 The findings of the gel electrophoresis method demonstrated
that the Zn(II) phthalocyanine compound binds to the CT-DNA molecules. The changes in the bands of the
DNA were observed in lanes 1 to 3 when these bands were compared to the control DNA (C), as indicated
in Figure 7. Lane C represents the control CT-DNA and lanes 1, 2, and 3 belong to the CT-DNA and PcZn
complex. Lane M shows the DNA marker. When the interactive ability of PcZn with CT-DNA was compared
to lane C, it indicated that the PcZn compound shows an effective binding activity with CT-DNA. It was
seen that the C band did not show any considerable change. As a result, the findings of the gel electrophoresis
experiments explicitly demonstrated that PcZn binds to CT-DNA.
2.7. Viscosity measurements
Viscosity studies are predominantly used to investigate the interaction of DNA molecules with metal complexes
via the increase and decrease in viscosity of DNA after adding the metal complexes. Increasing viscosity
demonstrates that metal complexes interact with DNA molecules through intercalative binding mechanisms
that lead to the degeneracy and extension of the DNA molecule. In contrast, a decrease in viscosity signifies
1316
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Figure 8. The relative viscosity of CT-DNA with increasing concentrations of PcZn and EB.

that metal complexes bind to DNA molecules via nonintercalative binding mechanisms. The packing of the
ligands of metal compounds between the base pairs of DNA leads to a considerable shift in the DNA’s molecular
structure. 30,31 Viscosity experiments were performed to investigate the interaction of PcZn with CT-DNA, as
shown in Figure 8. In the absence of CT-DNA and PcZn, the relative viscosity of EB was measured. Later,
in the presence of EB, the relative viscosity of CT-DNA and PcZn was monitored. As shown in Figure 8,
the viscosity of CT-DNA increased on successive additions of the PcZn complex. This result showed that the
PcZn complex interacts with CT-DNA via partial intercalative binding mechanisms.
2.8. Conclusions
In this study, the interaction of a PcZn complex with CT-DNA was investigated using electronic absorption
spectroscopy, emission titration, a thermal melting temperature study, viscosity measurements, cyclic voltammetry, and gel electrophoresis methods. Electronic absorption spectra, emission titration, and thermal melting
temperature studies demonstrated that the zinc(II) phthalocyanine complex interacts with CT-DNA through
a partial intercalative binding mechanism. The decrease in absorbance intensities of CT-DNA and PcZn supports the partial intercalative binding mechanism. The results of cyclic voltammogram studies demonstrated
successive decreases in peak current and the change in peak potential of the PcZn complex indicated that
CT-DNA interacts with the zinc(II) phthalocyanine complex. Similarly, the findings of the gel electrophoresis
study showed that PcZn interacts with CT-DNA. It is concluded that PcZn shows DNA binding activities
in a Tris-HCl buffer. The results demonstrated that the zinc(II) phthalocyanine complex could be a potential
candidate in treatment agents for cancer due to its DNA interaction.
3. Experimental
3.1. Chemicals and equipment
In this study, octaphenoxyacetamidephthalocyaninatozinc(II) 17 was used to investigate its interaction with CTDNA. Tris-HCl and CT-DNA samples were provided from Sigma-Aldrich and sodium chloride was purchased
from Merck. All the used chemical reagents and solvents were of biochemical grade. Therefore, they were used
without purification. The solutions of CT-DNA were prepared using Milli-Q water, which was obtained from a
commercial company.
Electronic absorption spectra for the binding activities of CT-DNA with the zinc(II) phthalocyanine complex (PcZn) were performed using Agilent Technologies Cary 60 UV/Vis spectroscopy. Emission spectroscopy
1317
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studies were carried out using PerkinElmer LS fluorescence spectroscopy. An Ivisumstat electrochemical analyzer was used for cyclic voltammetric (CV) studies. The Thermo Scientific Owl Electrophoresis System was
used for the gel electrophoresis method. Thermal melting temperature was studied at 260 nm using UV/Vis
spectroscopy. An Ubbelohde viscometer was used for viscosity measurements. All methods were performed in
a Tris-HCl buffer solution at a pH of 7.2 at room temperature.
3.2. Synthesis of compounds
3.2.1. The preparation of 1, 2-bis(phenoxyacetamide)-4,5-dicyanobenzene compound
The 1,2-bis(phenoxyacetamide)-4,5-dicyanobenzene compound was prepared and characterized according to the
literature procedure. 17
3.3. Electronic absorption spectra and emission spectroscopy studies
Electronic absorption titrations were performed between 300 and 800 nm. Absorption titration spectra for
the Zn(II) phthalocyanine complex at a fixed concentration of PcZn in a Tris-HCl buffer at a pH of 7.2 were
obtained by increasing the concentration of CT-DNA from 0.5 to 5 µ M. For determining dilution affects, the
results were compared to those of control titrations with Tris-HCl buffer solution instead of the DNA. 32 For the
phthalocyanine complex, the binding constant ( Kb ) was obtained from the Wolfe–Shimmer equation: 33
[DN A]/(εa − εf ) = [DN A]/(εb − εf ) + 1/(Kb(εb − εf ))

(1)

Here, εa, εf, and εb are the absorption coefficients. Kb is calculated from the ratio of slope to intercept. The
plot is obtained from

[DN A]
(εbεf )

versus [ DN A ].

In addition to the above study, further verifying the interaction of CT-DNA with octaphenoxyacetamidephthalocyaninatozinc(II), competitive DNA binding studies of PcZn with EB were performed using electronic
absorption spectra. Initially, the EB and CT-DNA complex was produced by adding EB to a CT-DNA sample.
Later, PcZn was added to the EB + CT-DNA complex. Then the changes in absorbance of EB and CT-DNA
were monitored. 30
The emission titration studies were conducted between 500 and 750 nm after excitation. Emission titration
spectra experiments were performed with increasing amounts of CT-DNA added to a PcZn sample at a fixed
concentration. After adding DNA to PcZn, the solution was allowed to reach chemical equilibrium for a certain
period of time before the measurements were recorded. 34,35
3.4. Cyclic voltammetry study
For this experiment, for cyclic voltammetric studies, an Ivisumstat Electrochemical Interface Electrochemical
Analyzer was used at a glassy carbon. An Ag/AgCl reference electrode, a glassy carbon working electrode, and
a platinum wire counter electrode were used in this part of study. A single-compartment three-electrode cell
system of 10 mL capacity was used to perform the experiments. 35 In this technique, all CV measurements were
recorded in a Tris-HCl buffer solution at a pH of 7.2.
3.5. Thermal melting temperature study
The study of thermal melting temperature ( Tm ) of CT-DNA is a measurement of stability of double-stranded
DNA with temperature. 13 In the absence and presence of the PcZn complex, the study of Tm was recorded
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for CT-DNA. CT-DNA and PcZn sample in buffer at a pH of 7.2 consisting of NaCl solution were heated from
25 ◦ C to 95 ◦ C progressively every 5 min. The values of electronic absorption titration were recorded after
each heating of the sample. The Tm measurements were performed at 260 nm 36−39 using Agilent Technologies
Cary 60 UV/Vis spectroscopy.
3.6. Viscosity measurement studies
In this technique, the viscosity measurements of PcZn with CT-DNA were recorded using an Ubbelohde
viscometer that was put in a water bath at a constant temperature around 30 ◦ C. CT-DNA concentration
was kept constant while the concentrations of PcZn and EB were increased gradually to investigate the DNA
binding activity of PcZn with CT-DNA. The approximate flow time was measured by testing the sample three
times. In the absence and presence of the compound, the solution viscosity was calculated with ηi = (ti − t0 )/t0,
where ηi is the viscosity value of CT-DNA, ti is the flow time of the PcZn and CT-DNA solution, and t0
is the flow time of the buffer solution at a pH of 7.2. The values of findings were indicated as ( η /η0 )1/3 vs.
[PcZn]/[DNA], where η is the viscosity of CT-DNA in the presence of the compound and η0 is the viscosity
of the DNA. 40
3.7. Gel electrophoresis experiment
In this method, gel electrophoresis experiments were carried out in 20 mM of Tris-HCl buffer system at a pH
of 7.2 consisting of 20 m NaCl. The binding of PcZn to CT-DNA was studied using agarose gel in Tris-HCl
buffer EDTA (TBE) solution. The CT-DNA (15 µ M) and PcZn (5 to 20 µ M) samples were loaded with
the dye in the buffer solution. The gel electrophoresis measurements were performed at 80 V for 3 h in TBE
solution. Then, in gel electrophoresis experiments, CT-DNA bands were visualized using a UV lamp. In this
work, the Thermo Scientific Owl Gel Electrophoresis system and a 1-kb DNA standard marker were used for
the experiments. 41−45
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